Expression of KAI1 in paraffin-embedded normal, hyperplastic and neoplastic prostate and prostate carcinoma cell lines

Pathology International

Volumn 48, Issue 2, 1998, Pages 87-92

  Ward, Jerrold M ^a   Konishi, Noboru ^c   Ohshima, Masato ^d   Lamb, Patricia W ^b   Jorcyk, Cheryl L ^a,e   Barrett, J Carl ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c NARA MEDICAL UNIVERSITY   (Japan)

^d Nissei Hospital   (Japan)

^e BOISE STATE UNIVERSITY   (United States)

Author keywords

Benign prostatic hyperplasia; Immunohistochemistry; KAI1; Prostate; Prostatic intraepithelial neoplasia

Indexed keywords

TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; FROZEN SECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; RAT; TUMOR SUPPRESSOR GENE;

EID: 0031980561     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1998.tb03876.x     Document Type: Article

References (13)

1. Dong JT, Lamb PW, Rinker-Schaeffe CW et al. KAI1, a metastasis suppressor gene for prostate cancer on human chromosome II. Science 1995; 268: 884-886.
2. Dong JT, Suzuki H, Pin SS et al. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss. Cancer Res. 1996; 56: 4387-4390.
3. Guo X, Friess H, Graber HU et al. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res. 1996; 56: 4876-4880.
4. Ueda T, Ichikawa T, Tamaru J et al. Expression of KAI1 protein in benign prostatic hyperplasia and prostate cancer. Am. J. Pathol. 1996; 149: 1435-1440.
5. Adachi M, Taki T, Leki Y, Huang CL, Higashiyama M, Miyake M. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer. Cancer Res. 1996; 56: 1751-1755.
6. Kawana Y, Komiya A, Ueda T et al. Location of KAI1 on the short arm of human chromosome 11 and frequency of allelic loss in advanced human prostate cancer. Prostate 1997; 32: 205-213.
7. Wei LL, Yang X, Philips K, Weissman BE, Welch DR. Analysis of KAI1 mRNA expression in human breast cancer cell lines (abstract). Proc. Am. Assoc. Cancer Res. 1996; 37: 529.
8. Fukudome K, Furuse M, Imai T et al. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: Altered glycosylation of C33 antigen in HTLV-1-positive T cells. J. Virol. 1992; 66: 1394-1401.
9. Lebel-Binay S, Lagaudriere C, Fradelizi D, Conjeaud H. CD82, member of the tetra-span-transmembrane protein family, is a costimulatory protein for T-cell activation. J. Immunol. 1995; 155: 101-110.
10. Ward JM, Perantoni AO, Santos E. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans. Oncogene 1989; 4: 203-213.
11. Imai T, Fukudome K, Takagi S et al. C33 antigen recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1-induced syncytium formation is a new family of transmembrane proteins including CD9, CD37, CD53, and CD63. J. Immunol. 1992; 149: 2879-2886.
12. Lebel-Binay S, Gil ML, Lagaudriere C et al. Further characterization of CD82/IA4 antigen (type III surface protein): An activation/differentiation marker of mononuclear cells. Cell. Immunol. 1994; 154: 468-483.
13. Nagira M, Imai T, Ishikawa I, Uwabe KI, Yoshi O. Mouse homologue of C33 antigen (CD82), a member of the transmembrane 4 superfamily: Complementary DNA, genomic structure, and expression. Cell. Immunol. 1994; 157: 144-157.